ENDRA Life Sciences Inc. (NASDAQ:NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care (POC) or field diagnostic hybrid of an ultrasound and MRI that can monitor the progression of one of the largest unmet medical needs worldwide.
Ophthalmologists and optometrists can use the device to image blood flow dynamics during retinal exams, helping them spot age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions. Millions are affected by these diseases, the company noted, and some are indicative of more serious medical problems.
Aethlon Medical received the OK from the FDA to test its blood-filtering device on severe COVID-19 patients…
The IB-Stim has received marketing approval from the U.S. Food and Drug Administration as the first medical device used to help alleviate functional abdominal pain in 11- to 18-year-old patients with irritable bowel syndrome (IBS), the agency announced Friday.
“Medtech companies’ calls with investors following the first quarter offered some stark figures on the steep drop-off in elective procedures in light of COVID-19.
BD said its surgery revenues were down as much as 70% in April. Stryker, which estimated half of its business was vulnerable to deferrable procedures, projected a nearly 40% drop in April sales. At Boston Scientific and Smith & Nephew, that revenue cut was closer to 50%. Intuitive Surgical, one of the earliest major medtechs to report earnings, said da Vinci robot use fell 65% in late March.”
CLEW is awarded FDA Emergency Use Authorization (EUA) for its predictive analytics platform, TeleICU in support of COVID-19 patients.
Intertek Receives Medical Device Regulation Designation
MDR is a new set of regulations for the manufacturing of medical devices in the EU.
May 15, 2020
…| May 15, 2020…
Sourced through Scoop.it from: www.marketscreener.com
BioIntelliSense has expanded its medical-grade biosensor product portfolio and Data-as-a-Service (DaaS) platform with the introduction of new BioButton device.
Sourced through Scoop.it from: www.nsmedicaldevices.com
As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in the world to treat a patient with COVID-19 using a modified dialysis device.
Sourced through Scoop.it from: www.news-medical.net
In an open-label study, more than half of patients with essential tremor experienced at least a 50% improvement in hand tremors using a wrist-worn neuromodulation device.
Sourced through Scoop.it from: www.medscape.com